CBS 2019
CBSMD教育中心
中 文

Acute Coronary Syndrom

Abstract

Recommended Article

Investigating methotrexate toxicity within a randomized double-blinded, placebo-controlled trial: Rationale and design of the Cardiovascular Inflammation Reduction Trial-Adverse Events (CIRT-AE) Study Complete Versus Culprit-Only Lesion Intervention in Patients With Acute Coronary Syndromes Prognostic and Practical Validation of Current Definitions of Myocardial Infarction Associated With Percutaneous Coronary Intervention Predicting Major Adverse Events in Patients With Acute Myocardial Infarction Effect of Smoking on Outcomes of Primary PCI in Patients With STEMI Inflammatory Bowel Disease and Acute Coronary Syndromes: From Pathogenesis to the Fine Line Between Bleeding and Ischemic Risk Unloading the Left Ventricle Before Reperfusion in Patients With Anterior ST-Segment-Elevation Myocardial Infarction Association Between Haptoglobin Phenotype and Microvascular Obstruction in Patients With STEMI: A Cardiac Magnetic Resonance Study

Clinical Trial2017 Aug;47(1):133-142.

JOURNAL:Semin Arthritis Rheum. Article Link

Investigating methotrexate toxicity within a randomized double-blinded, placebo-controlled trial: Rationale and design of the Cardiovascular Inflammation Reduction Trial-Adverse Events (CIRT-AE) Study

Sparks JA, Barbhaiya M, Karlson EW et al. Keywords: Genetics; Methotrexate; Pharmacovigilance; Polyglutamate; Toxicity

FULL TEXT PDF